Bloomberg Business Highlights Ketamine’s Rise to Treat Suicide Ideation

Bloomberg Business Highlights Ketamine’s Rise to Treat Suicide Ideation Bloomberg Businessweek recently ran an article by Cynthia Koons and Robert Langreth titled, “Ketamine Could Be the Key to Reversing America’s Suicide Rate”, highlighting Ketamine as a treatment option for treating suicidality and depression. This article is a great comprehensive analysis of Ketamine’s rise in the treatment of mental…

KWC named one of 2018’s Best Entrepreneurial Companies in America

KWC named one of 2018’s Best Entrepreneurial Companies in America On the heels of 2017’s placing # 329 on the Best 500 Best Entrepreneurial Companies in America annual list, Ketamine Wellness Centers has been once again recognized by Entrepreneur magazine’s Entrepreneur360™ list. We gained some traction too, having landed on the # 228 spot on this…

New York Times Highlights Ketamine in the Treatment of Suicide

New York Times Highlights Ketamine in the Treatment of Suicide The New York Times recently ran an op-ed piece by Moises Velasquez-Manoff titled, “Can We Stop Suicides”, highlighting Ketamine as a breakthrough treatment option for treating suicidality and depression. This publication covers the story of a woman named Louise who struggled with depression and suicidality…

New Study Suggests Ketamine Involved With Opioid Receptors

Recently, a small study was conducted by a team at Stanford University and their conclusions were published by The American Journal of Psychiatry. Results of the study spread far and wide among mainstream press and science/tech publications. The study provides a suggestions that Ketamine activates the brain’s opioid receptors (which control reward/addiction) in addition to what has…

WebMD Health News Investigates Ketamine’s Popularity in the Treatment of Depression

WebMD Health News has produced a well-researched piece entitled “Ketamine: A ‘Lifesaving’ Aid for Depression?“. It’s worth reading to get a broad look at the entire Ketamine playing field, featuring interviews with mental health professionals, Ketamine infusion providers, and those hoping for FDA approval of non-infusion medications or vehicles for Ketamine. While there are many…